Tag: Healthcare & Life Sciences
-
Pricing strategy consulting
Most pricing problems are not actually price problems. They are strategy problems, capability problems, and execution problems. Treating them as anything less is why so many pricing initiatives fail to stick.
-
Life Sciences: Adapting to a Changing Landscape
The life sciences industry must navigate rising inflation, a patent expiry cliff, regulatory shifts, and reduced M&A activity. Generative AI and automation are transforming drug discovery and processes, while companies focus on mass-market treatments and telehealth expansion. Strategic pricing and operational optimization will be critical for resilience and growth.
-
2024 Healthcare Services Pricing Benchmarks
We analyzed the responses from our 2024 Executive Pricing Survey and uncovered actionable insights for companies in Healthcare Services across North America and Europe.
-
2024 Medical Technology Pricing Benchmarks
We analyzed the responses from our 2024 Executive Pricing Survey and uncovered actionable insights for companies in Medical Technology across North America and Europe.
-
2024 Pharmaceuticals Pricing Benchmarks
We analyzed the responses from our 2024 Executive Pricing Survey and uncovered actionable insights for companies in Pharmaceuticals across North America and Europe